Esaote Enters The World Of Total Body MRI With Magnifico Open

Latest-generation open MRI for excellent diagnostic quality, patient comfort and low operating costs. Magnifico Open enriches the range of Esaote products presented in 2021.

Esaote, a leading Italian company in the biomedical sector—in ultrasound, dedicated magnetic resonance imaging, and information technology for healthcare— enters the world of total body magnetic resonance imaging with the new system called “Magnifico Open”.

Magnifico Open comes forth out of Esaote’s over 30 years of MRI experience. With Magnifico Open, Esaote proposes an open MRI system with cutting-edge technology to satisfy not only the clinical needs but also addressing operational and financial demands. An ample choice of receiving coils and state-of-the-art MRI technology offers the user an excellent image quality whereas the permanent magnet makes for simple installation and low operating costs.  The open magnet and easy-to-access patient table facilitate fast and comfortable patient positioning, ideal for claustrophobic patients and children alike.

Magnifico Open is equipped with most recent Esaote technologies like Speed Up, to assure optimal image quality in reduced examination times, True-Motion real-time imaging, offering a complementary approach to standard MRI for a more comprehensive clinical and diagnostic picture, particularly in high-level sports medicine, or MAR (Metal Artifact Reduction) allowing excellent image quality also for post-surgical imaging. Magnifico Open  aims to become the gold standard in the field of open Magnetic Resonance Imaging.

“In recent years, the technological evolution of MRI has seen major developments. At Esaote we have been working for over 30 years in the MRI sector to reach ever new horizons and 2021 is for us a year with a wealth of new products, confirming our constant commitment to innovation and the development of cutting-edge technologies,” commented Franco Fontana, Esaote CEO. “Today with Magnifico Open we are looking even more toward the future. With our experience and thanks to continual cooperation with many medical and scientific partners, we are entering the field of full body magnetic resonance imaging. This is an important achievement, which fills us with pride and opens us to new challenges.”

Magnifico Open is to be presented on Friday, 8 October 2021 with an exclusive streaming event on several platforms. The event, part of the Esaote “Exploring the Inside” program, is dedicated to the theme of the Challenge. The event is going to be hosted by illustrious figures such as the professional apneist Umberto Pellizzari and distinguished medical experts. https://www.mri-magnifico.com/

Other Esaote news here.

SourceEsaote

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.